24
total announcements
500660.BO · 15 min delayed
GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd has announced its Q1 FY2027 results, with revenue from operations at Rs. 92442 lakhs and profit before exceptional items and tax at Rs. 33798 lakhs. The company has also announced the re-appointment of Mr. Bhushan Akshikar as Managing Director and the appointment of Ms. Karine J F Natland as Non-Executive Director.
GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd announced its Q1 FY2026 financial results, with revenue from operations at Rs. 92442 lakhs, and profit before exceptional items and tax at Rs. 33798 lakhs. The company also announced the re-appointment of Mr. Bhushan Akshikar as a Managing Director and the appointment of Ms. Karine J F Natland as a Non-Executive Director. Mr. Subesh Williams stepped down from the Board.
GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd has scheduled an analyst/institutional investor meeting on August 3rd, 2026, to share information already in the public domain.
GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 03/08/2026 to consider and approve the un-audited financial results for the first quarter ended 30th June 2026.